Immunogenicity of Plasmodium falciparum and Plasmodium vivax circumsporozoite protein repeat multiple antigen constructs (MAC)

By Udhayakumar V.   Saekhou A.   Fang S.   Jue D.   Wohlhueter R.M.   Lal A.A.  

Vaccine, Vol. 16, Iss. 9, 1998-05 ,pp. : 982-988

Elsevier

Access to resources Recommend Favorite

Plasmodium falciparum circumsporozoite vaccine immunogenicity and efficacy trial with natural challenge quantitation in an area of endemic human malaria of Kenya

By Sherwood J.A.   Copeland R.S.   Taylor K.A.   Abok K.   Oloo A.J.   Were J.B.O.   Strickland G.T.   Gordon D.M.   Ballou W.R.   Bales J.D.   Wirtz R.A.   Wittes J.   Gross M.   J. U.Q.   Cryz S.J.   Oster C.N.   Roberts C.R.   Sadoff J.C.  

Vaccine, Vol. 14, Iss. 8, 1996-06 ,pp. : 817-827

Elsevier

Access to resources Recommend Favorite

A glycosylphosphatidylinositol anchor signal sequence enhances the immunogenicity of a DNA vaccine encoding Plasmodium falciparum sexual-stage antigen, Pfs230

By Fanning S.L.   Czesny B.   Sedegah M.   Carucci D.J.   van Gemert G.-J.   Eling W.   Williamson K.C.  

Vaccine, Vol. 21, Iss. 23, 2003-07 ,pp. : 3228-3235

Elsevier

Access to resources Recommend Favorite

Immunogenicity of chimeric multiple antigen peptides based on Plasmodium falciparum antigens: impact of epitope orientation

By Ahlborg N.   Nardin E.H.   Perlmann P.   Berzins K.   Andersson R.  

Vaccine, Vol. 16, Iss. 1, 1998-01 ,pp. : 38-44

Elsevier

Access to resources Recommend Favorite

Safety, tolerability and immunogenicity of new formulations of the Plasmodium falciparum malaria peptide vaccine SPf66 combined with the immunological adjuvant QS-21

By Kashala O.   Amador R.   Valero M.V.   Moreno A.   Barbosa A.   Nickel B.   Daubenberger C.A.   Guzman F.   Pluschke G.   Patarroyo M.E.  

Vaccine, Vol. 20, Iss. 17, 2002-05 ,pp. : 2263-2277

Elsevier

Access to resources Recommend Favorite